• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性心力衰竭时肺泡-毛细血管膜扩散能力降低。其病理生理相关性及与运动能力的关系。

Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.

作者信息

Puri S, Baker B L, Dutka D P, Oakley C M, Hughes J M, Cleland J G

机构信息

Department of Medicine (Clinical Cardiology and Respiratory Medicine), Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

出版信息

Circulation. 1995 Jun 1;91(11):2769-74. doi: 10.1161/01.cir.91.11.2769.

DOI:10.1161/01.cir.91.11.2769
PMID:7758183
Abstract

BACKGROUND

The pulmonary diffusing capacity for carbon monoxide (DLCO) is reduced in chronic heart failure (CHF) and is an independent predictor of peak exercise oxygen uptake. The pathophysiological basis for this remains unknown. The aim of this study was to partition DLCO into its membrane conductance (DM) and capillary blood volume components (Vc) and to assess if alveolar-capillary membrane function correlated with functional status, exercise capacity, and pulmonary vascular resistance.

METHODS AND RESULTS

The classic Roughton and Forster method of measuring single-breath DLCO at varying alveolar oxygen concentrations was used to determine DM and Vc in 15 normal subjects and 50 patients with CHF. All performed symptom-limited maximal bicycle exercise tests with respiratory gas analysis; 15 CHF patients underwent right heart catheterization. DLCO was significantly reduced in CHF patients compared with normal subjects, predominantly because of a reduction in DM (7.0 +/- 2.6 versus 12.9 +/- 3.8 versus 20.0 +/- 6.1 mmol.min-1.kPa-1 in New York Heart Association class III, class II, and normal subjects, respectively, P < .0001), even when the reduction in lung volumes was accounted for by the division of DM by the effective alveolar volume. The Vc component of DLCO was not impaired. DM significantly correlated with maximal exercise oxygen uptake (r = .72, P < .0001) and inversely correlated with pulmonary vascular resistance (r = .65, P < .01) in CHF.

CONCLUSIONS

Reduced alveolar-capillary membrane diffusing capacity is the major component of impaired pulmonary gas transfer in CHF, correlating with maximal exercise capacity and functional status. DM may be a useful marker for the alveolar-capillary barrier damage induced by raised pulmonary capillary pressure.

摘要

背景

慢性心力衰竭(CHF)患者的肺一氧化碳弥散量(DLCO)降低,且是运动峰值摄氧量的独立预测指标。其病理生理基础尚不清楚。本研究的目的是将DLCO分为膜传导率(DM)和毛细血管血容量成分(Vc),并评估肺泡-毛细血管膜功能是否与功能状态、运动能力和肺血管阻力相关。

方法与结果

采用经典的Roughton和Forster方法,在不同肺泡氧浓度下测量单次呼吸DLCO,以确定15名正常受试者和50名CHF患者的DM和Vc。所有受试者均进行了症状限制的最大运动自行车试验并进行呼吸气体分析;15名CHF患者接受了右心导管检查。与正常受试者相比,CHF患者的DLCO显著降低,主要是由于DM降低(纽约心脏协会III级、II级和正常受试者的DM分别为7.0±2.6、12.9±3.8和20.0±6.1 mmol·min-1·kPa-1,P<.0001),即使通过将DM除以有效肺泡容积来校正肺容积减少的影响。DLCO的Vc成分未受损。在CHF患者中,DM与最大运动摄氧量显著相关(r=.72,P<.0001),与肺血管阻力呈负相关(r=.65,P<.01)。

结论

肺泡-毛细血管膜弥散能力降低是CHF患者肺气体交换受损的主要因素,与最大运动能力和功能状态相关。DM可能是肺毛细血管压力升高所致肺泡-毛细血管屏障损伤的有用标志物。

相似文献

1
Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance.慢性心力衰竭时肺泡-毛细血管膜扩散能力降低。其病理生理相关性及与运动能力的关系。
Circulation. 1995 Jun 1;91(11):2769-74. doi: 10.1161/01.cir.91.11.2769.
2
Gas diffusion and alveolar-capillary unit in chronic heart failure.慢性心力衰竭中的气体扩散与肺泡-毛细血管单位
Eur Heart J. 2006 Nov;27(21):2538-43. doi: 10.1093/eurheartj/ehl302. Epub 2006 Oct 6.
3
Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.同时测量肺弥散能力和肺血流动力学揭示射血分数保留的心力衰竭患者运动时肺泡-毛细血管功能障碍。
J Am Heart Assoc. 2021 Aug 17;10(16):e019950. doi: 10.1161/JAHA.120.019950. Epub 2021 Aug 7.
4
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.肺结节病中肺一氧化碳弥散能力的膜性和毛细血管血液成分:与运动气体交换的关系
Chest. 2004 Jun;125(6):2061-8. doi: 10.1378/chest.125.6.2061.
5
Lung membrane diffusing capacity, heart failure, and heart transplantation.肺膜弥散能力、心力衰竭与心脏移植
Am J Cardiol. 1999 Jan 1;83(1):62-7. doi: 10.1016/s0002-9149(98)00784-x.
6
Effect of circulatory congestion on the components of pulmonary diffusing capacity in morbid obesity.循环充血对病态肥胖患者肺弥散能力各组成部分的影响。
Obesity (Silver Spring). 2006 Jul;14(7):1172-80. doi: 10.1038/oby.2006.134.
7
Pulmonary membrane diffusing capacity and capillary blood volume measured during exercise from nitric oxide uptake.运动期间通过一氧化氮摄取量测定的肺膜弥散能力和毛细血管血容量。
Chest. 2001 Dec;120(6):1850-6. doi: 10.1378/chest.120.6.1850.
8
Decrease by ACE-inhibition of the excessive alveolar-capillary membrane resistance to gas transfer in chronic heart failure.在慢性心力衰竭中,通过血管紧张素转换酶抑制作用降低过度的肺泡-毛细血管膜对气体交换的阻力。
Cardiologia. 1998 Jun;43(6):625-30.
9
Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.心力衰竭患者运动期间肺泡-毛细血管募集率降低及肺弥散能力下降。
J Card Fail. 2006 May;12(4):299-306. doi: 10.1016/j.cardfail.2006.01.010.
10
Are there sex differences in the capillary blood volume and diffusing capacity response to exercise?毛细血管血容量和弥散能力对运动的反应存在性别差异吗?
J Appl Physiol (1985). 2017 Mar 1;122(3):460-469. doi: 10.1152/japplphysiol.00389.2016. Epub 2016 Dec 8.

引用本文的文献

1
Short-term effects of DAPAgliflozin on Lung fUNction, sleep apneas, and circulatinG surfactant protein B in Heart Failure with reduced ejection fraction (DAPA-LUNG-HF).达格列净对射血分数降低的心力衰竭患者肺功能、睡眠呼吸暂停及循环表面活性蛋白B的短期影响(DAPA-LUNG-HF研究)
Int J Mol Sci. 2025 Aug 8;26(16):7696. doi: 10.3390/ijms26167696.
2
Exercise Training in Heart Failure: Clinical Benefits and Mechanisms.心力衰竭中的运动训练:临床益处与机制
Circ Res. 2025 Jul 7;137(2):273-289. doi: 10.1161/CIRCRESAHA.124.325533. Epub 2025 Jul 3.
3
The impact of long COVID on physical and cardiorespiratory parameters: A systematic review.
新冠长期症状对身体和心肺参数的影响:一项系统综述。
PLoS One. 2025 Jun 4;20(6):e0318707. doi: 10.1371/journal.pone.0318707. eCollection 2025.
4
A roadmap for therapeutic discovery in pulmonary hypertension associated with left heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function.左心衰竭相关性肺动脉高压治疗探索路线图。欧洲心脏病学会心力衰竭协会(HFA)和欧洲心脏病学会肺循环与右心室功能工作组的科学声明。
Eur J Heart Fail. 2024 Apr;26(4):707-729. doi: 10.1002/ejhf.3236. Epub 2024 Apr 19.
5
Two is better than one: the double diffusion technique in classifying heart failure.两个比一个好:双扩散技术在心力衰竭分类中的应用
ERJ Open Res. 2024 Jan 15;10(1). doi: 10.1183/23120541.00644-2023. eCollection 2024 Jan.
6
Correlation between Cardiovascular Autonomic and Pulmonary Ventilation Functions in Myasthenia Gravis Patients.重症肌无力患者心血管自主与肺通气功能的相关性。
Adv Respir Med. 2023 Dec 1;91(6):546-559. doi: 10.3390/arm91060040.
7
Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study.吡非尼酮和尼达尼布的比较:特发性肺纤维化清除研究的事后分析。
Chest. 2024 May;165(5):1163-1173. doi: 10.1016/j.chest.2023.11.035. Epub 2023 Nov 27.
8
The added value of haemoglobin to height, age, and sex to predict DLCO in subjects with preserved exercise capacity.血红蛋白对身高、年龄和性别在预测运动能力正常者 DLCO 中的附加价值。
PLoS One. 2023 Aug 8;18(8):e0289540. doi: 10.1371/journal.pone.0289540. eCollection 2023.
9
Resting pulmonary function and artery pressure and cardiopulmonary exercise testing in chronic heart failure patients in Taiwan - a prospective observational cross-sectional study comparing healthy subjects and interstitial lung disease patients.台湾地区慢性心力衰竭患者的静息肺功能、动脉压和心肺运动试验——一项比较健康受试者和间质性肺疾病患者的前瞻性观察性横断面研究。
Ann Med. 2023 Dec;55(1):2228696. doi: 10.1080/07853890.2023.2228696.
10
Lung diffusion capacity correlates with pre-implant pulmonary hypertension and predicts outcome after LVAD implantation.肺扩散能力与植入前肺动脉高压相关,并可预测 LVAD 植入后的结果。
ESC Heart Fail. 2023 Apr;10(2):1043-1053. doi: 10.1002/ehf2.14256. Epub 2022 Dec 22.